Commercial Credit Report for Pangaea Oncology SA

CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals. Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue. We also offer solutions that can help ease private company financial risk assessment. Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively.

A partial report preview for Pangaea Oncology SA is shown below. Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database. To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

	Pangaea Oncology SA
Quiron Dexeus University Hospital
C/ Sabino Arana, 5-19
Phone: +34 934097981p:+34 934097981	BARCELONA, BAR 08028 Spain	Ticker: PANGPANG

Business Summary

Pangaea Oncology SA is a Spain-based company primarily engaged in the biotechnology sector. The Company focuses on the development of oncology treatments. The Company’s activities are divided into two business lines: Clinical care in the Dr. Rosell Oncology Institute (IOR) and Molecular diagnosis (Dx). The IOR division offers personalized medical services related to oncology area, such as diagnosis, laboratory testing and treatment, in a chain of hospitals in Catalonia, Spain. The Dx division is responsible for the development of diagnostic and in-vitro services, biomarkers, as well as targeted drugs for patients and pharmaceutical companies. Its diagnostic models include Liquid Biopsy and Multiplexing.

Scores and Ratings

FRISK^® Score	Z'' Score	PAYCE^® Score	DBT Index	Moody's Rating	Fitch Rating	DBRS Rating
Yes	Yes	-	-	-	-	-

Financials, News and Filings

Latest Statement	Last Audit	News	SEC Filings	Bankruptcy Filings	Suit & Judgment Filings	Tax Lien Filings
12/31/2023	12/31/2023	Yes	-	-	-	-

Industries

SIC Code	Description
8731	Commercial physical and biological research
8069	Specialty hospitals, except psychiatric
8071	Medical laboratories

Officers and Directors

Title	Name	Title Date	Start Date
Executive Chairman of the Board, Representative of Topgenetics, SLU, Co-Founder, Chief Scientific O	RafaelRosell Costa	11/2/2016	11/2/2016
Chief Executive Officer, Co-Founder, Executive Director	JavierRivela Rodriguez	11/2/2016	11/2/2016
Vice Chairman of the Board, Proprietary Director, Representative of Biolifepat, SL	SantiagoRamon y Cajal Agueras	1/16/2023	11/2/2016
12 additional Officers and Directors records available in full report.

General Information

Number of Employees:	155	(As of 12/31/2023)
Outstanding Shares:	33,370,529	(As of 8/20/2024)
Stock Exchange:	MCE
Fax Number:	+34 935460172

SITE MAP | ABOUT US | DIRECTORY | STOCK QUOTE: CRMZ | SIGN IN